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Background: Pyridoxal 5′-phosphate (PLP)-dependent enzymes of fold type I, the most studied structural class of
the PLP-dependent enzyme superfamily, are known to exist as stand-alone homodimers or homotetramers. These
enzymes have been found also embedded in multimodular and multidomain assembly lines involved in the
biosynthesis of polyketides (PKS) and nonribosomal peptides (NRPS). The aim of this work is to provide a proteome-
wide view of the distribution and characteristics of type I domains covalently integrated in these assemblies in
prokaryotes.
Results: An ad-hoc Hidden Markov profile was calculated using a sequence alignment derived from a multiple
structural superposition of distantly related PLP-enzymes of fold type I. The profile was utilized to scan the
sequence databank and to collect the proteins containing at least one type I domain linked to a component of an
assembly line in bacterial genomes. The domains adjacent to a carrier protein were further investigated.
Phylogenetic analysis suggested the presence of four PLP-dependent families: Aminotran_3, Beta_elim_lyase and
Pyridoxal_deC, occurring mainly within mixed NRPS/PKS clusters, and Aminotran_1_2 found mainly in PKS clusters.
Sequence similarity to the reference PLP enzymes with solved structures ranged from 24 to 42% identity.
Homology models were built for each representative type I domain and molecular docking simulations with
putative substrates were carried out. Prediction of the protein-protein interaction sites evidenced that the surface
regions of the type I domains embedded within multienzyme assemblies were different from those of the self-
standing enzymes; these structural features appear to be required for productive interactions with the adjacent
domains in a multidomain context.
Conclusions: This work provides a systematic view of the occurrence of type I domain within NRPS and PKS
assembly lines and it predicts their structural characteristics using computational methods. Comparison with the
corresponding stand-alone enzymes highlighted the common and different traits related to various aspects of their
structure-function relationship. Therefore, the results of this work, on one hand contribute to the understanding of
the functional and structural diversity of the PLP-dependent type I enzymes and, on the other, pave the way to
further studies aimed at their applications in combinatorial biosynthesis.
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Pyridoxal 5′-phosphate (PLP), a derivative of Vitamin B6, is
one of the most versatile organic cofactors in biology. In
fact, PLP-dependent enzymes form a vast and complex
group of proteins present in organisms belonging to all
levels of the tree of life [1] and participate in a variety of re-
actions (Additional file 1: Scheme 1). In humans, for ex-
ample, besides the classical role in transamination, many of
these enzymes take part in the metabolism of neurotrans-
mitters such as dopamine, serotonin, glycine, epinephrine,
norepinephrine, D-serine, L-glutamate, γ-amino butyric
acid and histamine [2]. PLP-dependent enzymes have been
classified in at least five evolutionarily unrelated families,
characterized by specific three-dimensional folds [1,3].
Many studies have been devoted to the elaboration of a
rigorous classification of PLP enzymes, with the aim to
identify their common structural features and to under-
stand how different protein scaffolds can support similar
substrate binding in the active sites [4]. Among the different
structural classes, the so-called fold type I [5] is the most
populated in nature and the best characterized one. The
subunit architecture of the fold includes one large and one
small domain. The large domain contains a seven stranded
β-sheet interacting with α-helices. The small domain at the
C-terminal part of the chain folds as a three- or four-
stranded β-sheet partly covered with helices. PLP-enzymes
belonging to the fold type I, are known to exist as stand-
alone proteins either homodimers or homotetramers. The
active site is located in a crevice between the two domains
at the subunit interface. The archetypal protein of this class
is aspartate aminotransferase [6] which was the first PLP-
dependent enzyme to be purified and crystallized. Since
then, intense research work has been carried out to eluci-
date the details of its structural and functional properties.
Scrutiny of sequence data produced by genomic pro-
jects showed that fold type I domains can be found in
multidomain frameworks, in prokaryotic systems, such
as the transcriptional regulator MocR [7,8] and also in
multienzyme systems, polyketide synthases (PKS) and
nonribosomal peptide synthetases (NRPS), involved in
the biosynthesis of polyketides (PK), nonribosomal pep-
tides (NRP) and hybrid PK/NRP secondary metabolites.
A vast array of bioactive metabolites belonging to these
classes includes also several important medicinal agents
and biotechnologically relevant compounds [9,10]. The
canonical biosynthetic mechanisms of the two classes of
structurally different secondary metabolites, polyketides
(PK) and nonribosomal peptides (NRP), share several
common features. Both NRPS and PKS type I systems
require the participation of multienzyme complexes act-
ing as assembly lines for the construction of polyketide
or peptide chains by a sequence of condensation steps.
In both systems each elongation step is catalyzed by a
module containing the catalytic domains required forthe insertion of a monomer into the growing chain. The
first step in the biosynthetic pathway, is the ATP-
dependent adenylation of the amino acid catalyzed by
an adenylation domain (A) in the NRPS systems and the
transfer of the acyl-group from an acyl-CoA onto
the acyltransferase unit (AT) in the PKS systems. The
monomer is then transferred to a carrier protein (CP)
post-translationally primed with a phosphopantetheine
arm, called thiolation domain (T) or peptidyl carrier
protein (PCP) in NRPS and acyl carrier protein (ACP)
in PKS multienzyme assemblies, respectively. In both
systems, the carrier proteins mediate the transport of -
intermediates, linked by a thioester bond to the phos-
phopantetheine arm, along the assembly line. In NRPS
systems, the key elongation reaction is the peptide bond
formation by a nucleophilic attack of the α-amino group
of the amino acid tethered to the downstream thiolation
domain on the thioester bond of the intermediate teth-
ered to the upstream peptidyl carrier protein, catalyzed
by a condensation domain (C). In PKS assembly lines
the elongation relies on the ketosynthase (KS) catalyzed
carbon-carbon bond formation, by a Claisen condensa-
tion mechanism between the upstream acyl thioester
and the downstream carbanionic acyl acceptor resulting
from decarboxylation of malonyl- or methylmalonyl-
ACP. The release of the product in both systems is usu-
ally catalyzed by a thioesterase (TE) domain located
in the termination module and in most cases involves
a macrocyclization; however different mechanisms have
also been reported [9,10]. In addition to these two
distinct biosynthetic mechanisms, there is a large
number of mixed clusters involved in the production
of structurally complex compounds where both polyke-
tide and peptide moieties can be recognized. The modu-
lar architecture and functional versatility makes possible
the switching between NRPS and PKS assembly lines.
In NRPS, PKS and hybrid systems, besides the essen-
tial aforementioned catalytic domains, the presence
of additional “tailoring domains”, which introduce struc-
tural modifications into the canonical building blocks
and contribute to the amazing structural diversity in
NRP and PK metabolites, is frequently observed. These
domains can be encoded within the biosynthetic gene
clusters, either fused to other catalytic domains or as
self-standing domains [9]. Their activities range from
hydroxylation, halogenation, methylation, racemization,
heterocyclization, lipidation and glycosilation. Several
PLP-dependent proteins were also identified in multi-
modular biosynthetic machineries, some operating
as self-standing domains, others incorporated in multi-
domain enzymes containing at least one carrier protein.
Examples of PLP-dependent enzymes postulated to be
involved in the formation of building blocks are found
in the biosynthesis of peptidyl nucleoside antibiotic
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fold, and PacT belonging to the type I fold [11]. A PLP-
dependent protein is involved in an interesting and very
unusual chain releasing mechanism in the biosynthesis
of the fungal polyketide mycotoxin fumonisin, namely
by incorporation of two carbons and one amino group
from alanine into the acyl chain [12]. A stand-alone PLP
dependent enzyme, MxcL, is hypothesized to participate
in the final step of the biosynthesis of myxochelin B,
the catecholate siderophore produced by Stigmatella
aurantiaca Sg a15 [13], namely in the transamination
of the aldehyde group present in the late biosynthetic
intermediate. The insertion of an amino group into a
polyketide biosynthetic precursor by transamination of
the carbonyl function is a process operating also in the
biosynthesis of antimicrobial polyamino antibiotics zea-
mines produced by Serratia plymuthica RVH1 [14]. In
particular, the gene zmn12 present in the complex bio-
synthetic cluster of this compound, encodes a protein
containing a domain with a putative aminotransferase
activity, homologous to the type I PLP–dependent
glutamate-1-semialdehyde aminotransferase.
The functionally characterized PLP-dependent domains
belonging to fold type I which operate in cis within mixed
NRPS/PKS multienzyme systems are those involved in the
biosynthesis of the potent antifungal cyclic lipopeptide
mycosubtilin [15] and of the tripyrrolic metabolite prodi-
giosin [16]. In the biosynthesis of mycosubilin [15], an ami-
notransferase domain (AMT) embedded within the PKS/
NRPS hybrid enzyme MycA and located at the interface of
the PKS and NRPS modules, catalyzes the incorporation of
an amine group from the amine donor, Gln, into the
protein-bound PLP and subsequently to the β-ketothioester
tethered to the ACP domain of the polyketide moiety. A
different role of a PLP domain was established in the
formation of prodigiosin belonging to the family of tripyr-
role red pigments prodiginines produced by Serratia and
Streptomyces bacterial strains, which are attracting increas-
ing interest because of their immunosuppressive, antican-
cer, antimicrobial, and antimalarial activities. The PLP-
dependent domain, SerT, located on a module containing
also two ACP domains, PigH, is predicted to generate a C2
fragment by decarboxylation of L-serine, which is then used
for pyrrole B ring formation [16].
In this paper, we focus specifically on PLP-
dependent domains of fold type I occurring covalently
linked in multidomain frameworks related to NRPS
and/or PKS-like assemblies in bacterial systems. Since
the identification of these domains is relatively recent,
we undertook an in silico analysis with the aim
to contribute to the clarification of some aspects con-
cerning their function, structural remodeling and rela-
tionship to the homologous, traditional PLP-dependent
enzymes.Results
Construction of the hidden Markov model representative
of fold type I PLP enzymes
We have expanded the non-redundant set of proteins
belonging to the fold type I family (Table 1) already re-
ported [5]. Twelve new structures were included to ob-
tain a total of 31 fold type I proteins aligned (Figure 1).
The structurally conserved regions [17] belonging to the
large and small domain of the type I monomer have
been identified. Since the small domain is the most vari-
able among the fold type I proteins, the alignment por-
tion used in the HMM profile encompasses the regions
containing the major domain and the helix bridging the
minor domain. This region corresponds to the first 13
SCRs. The long insertions/deletions (indels) have been
kept in the alignment in order to confer the HMM
profile ability to adequately modeling the indels expected
to occur in distantly related structures. We will refer to
the HMM profile calculated from this alignment as
PLP_domain profile.
Detection of sequences containing the type I PLP-
domains through databank searches
At the completion of the databank searches, 206 se-
quences were collected using the criteria and the filter-
ing procedure reported in Methods section; a detailed
list is reported in Additional file 1: Table S1.
Phylogenic analysis of type I PLP domains embedded in
the NRPS or PKS multienzyme assemblies
The sequences corresponding to the type I PLP domains
were extracted from the parent sequences. A subset was
selected using the routine “skipredundant” of the EM-
BOSS suite [18] to remove sequences sharing more than
70% identity to one of the other. Thirty sequences were
retained from the initial set of 206 type I domains and
were multiply aligned. Phylogenetic analyses were ap-
plied to visualize the relationships among domain fam-
ilies. The resulting consensus tree reported in Figure 2
suggests that the type I domains can be divided into four
distinct groups.
The most numerous group corresponds to the Pfam
Aminotran_3 family (code PF00202) (Table 2), related to
the PLP AT-II family [19]. Members of the family are the
glutamate-1-semialdehyde 2,1-aminomutase [PDB:2E7U],
the acetylornithine aminotransferase [PDB:1VEF] and the
2,2-dialkylglycine decarboxylase [PDB:1DGE]. A second
group matches the Pfam family Aminotran_1_2 (PF00155)
structurally related to the PLP-dependent CoA family [19]
to which serine palmitoyltransferase [PDB:3A2B], 2-amino-
3-ketobutyrate CoA ligase [PDB:3TQX] and 8-amino-7
-oxononanoate synthase [PDB:1BS0] belong. The third
group coincides with the Pfam family Beta_elim_lyase
(PF01212) to which tyrosine phenol-lyase [PDB:3C7G],
Table 1 List of structures of PLP-dependent type-I domains utilized for the calculation of the PLP_domain profile
PDB codea) Enzyme description Source Resolution (Å)
1. 1AX4 Tryptophanase Proteus vulgaris 2.10
2. 1B9H 3-amino-5-hydroxybenzoate synthase Amycolatopsis mediterranei 2.00
3. 1BJ4 Serine hydroxymethyltransferase Homo sapiens 2.65
4. 1BJN Phosphoserine aminotransferase Escherichia coli 2.29
5. 1BJW Aspartate aminotransferase Thermus thermophilus 1.80
6. 1BS0 8-amino-7-oxononanoate synthase Escherichia coli 1.65
7. 1C7N Cystalysin Treponema denticola 1.90
8. 1CL1 Cystathionine beta-lyase Escherichia coli 1.83
9. 1D2F MalY protein Escherichia coli 2.50
10. 1DGD Dialkylglycine decarboxylase Burkholderia cepacia 2.80
11. 1DTY Adenosylmethionine aminotransferase Escherichia coli 2.14
12. 1ECX NifS-like protein Thermotoga maritima 2.70
13. 1ELQ L-cysteine/L-cystine C-S lyase Synechocystis sp. 1.80
14. 1FG3 Histidinol-phosphate aminotransferase Escherichia coli 2.20
15. 1H0C Alanine-glyoxylate aminotransferase Homo sapiens 2.50
16. 1IAX 1-aminocyclopropane-1-carboxylate synthase Lycopersicon esculentum 2.80
17. 1JS6 Dopa decarboxylase Sus scrofa 2.60
18. 1LK9 Alliin lyase Allium sativum 1.53
19. 1MDX ArnB aminotransferase Salmonella typhimurium 1.96
20. 1OAT Ornithine aminotransferase Homo sapiens 2.50
21. 1QGN Cystathionine gamma-synthase Nicotiana tabacum 2.90
22. 1SF2 4-aminobutyrate-aminotransferase Escherichia coli 2.40
23. 1WKG Acetylornithine aminotransferase Thermus thermophilus HB8 2.25
24. 2BWP 5-aminolevulinate synthase Rhodobacter capsulatus 2.70
25. 2FM1 Threonine Aldolase Thermotoga maritima 2.25
26. 2GSA Glutamate-1-semialdehyde 2,1-aminomutase Synechococcus sp. 2.40
27. 2JG2 Serine Palmitoyltransferase Pseudomonas paucimobilis 1.30
28. 2NMP Cystathionine gamma lyase Homo sapiens 2.60
29. 3BWO L-tryptophan aminotransferase Arabidopsis thaliana 2.40
30. 3EI7 LL-diaminopimelate aminotransferase Arabidopsis thaliana 1.99
31. 3FZ8 Glutamate decarboxylase beta Escherichia coli 3.00
a)Boldfaced codes denote the new structures added to the original set.
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last group, the least populated, is related to human cysteine
sulfinic acid decarboxylase [PDB:2JIS] and glutamic acid
decarboxylase [PDB:2OKK]. The Pfam name of this group
is Pyridoxal_deC (PF00282).
The results of the annotation of the type I domain se-
quences through the B6 database [20] show heterogeneity
with respect to the Pfam classification: the Aminotran_3
family indeed contains glutamate-1-semialdehyde 2,1-ami-
nomutase, taurine--pyruvate aminotransferase, diamine ami-
notransferase, diaminobutyrate-2-oxoglutarate transaminase,
ornithine--oxo-acid aminotransferase (Table 2). The Pfam
families Aminotran_1_2 and Beta_elim_lyase appear homo-
geneous since they contain only 8-amino-7-oxononanoatesynthase and tyrosine phenol lyase, respectively. The last
and the less populated family Pyridoxal_deC contains, as ex-
pected, decarboxylases namely diaminobutyrate decarboxyl-
ase and glutamate decarboxylase.
A phylogenetic tree for all the collected sequences was
calculated (Additional file 1: Figure S1). This tree con-
forms to the tree calculated for the type I sequence sub-
set reported in Figure 2.
Description of the domain architecture and sequence
analysis of multidomain assemblies containing type I PLP
enzymes
The organization and the identity of the domains con-
tained in the parent sequences from which the type I
Figure 1 Structurally Conserved Regions. Alignment of the Structurally Conserved Regions (SCR) of the 31 fold type I structures considered.
Colors indicate conservation of residue physico-chemical properties. Each structure is labeled by its PDB code flanked by the sequence positions
encompassing the reported SCRs. “SCR line” numbers the 13 conserved regions; below is the conservation histogram and the consensus
sequence. The identically conserved residues in position 69 and 85 are the Asp interacting with the cofactor pyridine nitrogen and the Lys
forming the Schiff base, respectively. Indels are not shown for easing the interpretation of the figure. Indel positions are denoted by the all-gap
columns separating the different SCRs.
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script “Pfam_scan.pl” (see Methods). These results and
those deriving from the antiSMASH [21,22] analysis are
summarized in Table 2 for the non-redundant subset
and in Additional file 1: Table S1 for the entire set, re-
spectively. Apparently, Aminotran_3 family represents
the vast majority of the type I domains collected. They
occur almost invariantly in mixed PKS/NRPS assemblies.
Regarding the family denoted by the Pfam tag Amino-
tran_1_2, it can be noted that many assemblies do not
contain more than three domains. However, they are
very likely involved in pathways related to NRPS or PKS
because the corresponding coding sequences are often
adjacent to those characteristic of such biosynthetic
clusters (results not shown). For example, the coding se-
quence [UniProt: A0SZ00] (Additional file 1: Table S2)
from Janthinobacterium lividum [GenBank:ABK64042],
is located between the sequences [GenBank:ABK64060]
and [GenBank:ABK64039], corresponding to a putative
peptidyl carrier protein and a putative L-prolyl-AMP-ligase,
respectively.
The Beta_elim_lyase domains occur in predicted
mixed PKS/NRPS transacting clusters. Interestingly, the
type I domains are incorporated in modules missing any
A or AT domain. This situation is reminiscent of thecluster involved in the biosynthesis of the mixed NRP/
PK metabolite leinamycin from Streptomyces atrooliva-
ceus S-140 [23] where the gene lnmJ encodes six PKS
modules lacking the AT domains and a domain homolo-
gous to tyrosine phenol-lyases ([UniProt: Q8GGP2] in
Table 2). It was also experimentally proved that the
missing activities were provided by a discrete AT en-
zyme that loads the extender units in trans [23,24].
Moreover, we found a similar example in the mixed
NRPS/PKS gene cluster 6 predicted by antiSMASH [22]
analysis of the genome of the bacteria Catenulispora
acidiphila. In this cluster, to which belongs the sequence
[UniProt:C7PXR3] shown in Table 2, the occurrence of a
stand-alone A domain ([UniProt:C7PXP4]) is predicted.
Pyridoxal_deC domains are the rarest since they occur
only in two instances of our set, one of which could not
be annotated by antiSMASH [22].
Molecular modeling of the type I domains and docking of
putative substrates
Homology modeling and molecular docking have been
applied to map the conserved residues onto the pre-
dicted structure of a representative domain of each fam-
ily and to envisage their functional role. Model-template
pairs were chosen so as to maximize their percentage of
 D3VEV4 - Xenorhabdus nematophila - Gammaproteobacteria - Nrp T1pks-nrps Nrp-Mal-Nrp-Asn
 G2E5C9 - Thiorhodococcus drewsii - Gammaproteobacteria - Mal, ThrNrps-t1pksNrp-Tyr-Pk-Mal-Thr-Asp
 C3AKA5 - Bacillus mycoides - Firmicutes - ? Nrps-transatpks Asn-Mal-Gly-Nrp-Nrp-Nrp-Thr-Gly
 D6KDX7 - Streptomyces sp. - Actinobacteria - ? - Nrps - Nrp-Mal-Nrp-Orn-Asp-Nrp-Nrp-Thr
 G0PR31 - Streptomyces griseus - Actinobacteria - ? - T1pks-nrps - Mal-Thr
 F7QBN5 - Salinisphaera shabanensis - Gammaproteobacteria - Gly,- - Nrps-t1pks - Gly-Mal-Nrp
 C6XWU5 - Pedobacter heparinus - Bacteroidetes - Nrp - Nrps-t1pks - Nrp-Mal-Gly-Pk
 F9UAS6 - Thiocapsa marina - Gammaproteobacteria - Mal - Nrps-t1pks - Nrp-Nrp-Mal-Gly
 Q2T5Z2 - Burkholderia thailandensis - Betaproteobacteria - Asp - Nrps-t1pks-hserlactone - Mal-Asp-Gln-Cys-Pk-Val-Mal-Ala
 2e7u
 F4CRB0 - Pseudonocardia dioxanivorans - Actinobacteria - ? - ? - ?
 1dge
 1vef
 C8RZN9 - Rhodobacter sp. - Alphaproteobacteria - Mal - Terpene-t1pks - Mal
 E1TD76 - Burkholderia sp.- Betaproteobacteria - ? - ? - ?
 A1YBQ7 - Sorangium cellulosum - Deltaproteobacteria - ? - T1pks - Mmal-Mmal-Mal-Mmal-Mal-Mmal-Mal-Mal-Pk
 C5B3B9 - Methylobacterium extorquens - Alphaproteobacteria - ? - ? - ?
 F5RC11 - Methyloversatilis universalis - Betaproteobacteria - ? - ? - ?
 F2LI38 - Burkholderia gladioli - Betaproteobacteria - ? - T2pks-transatpks-nrps - Mal-Gly-Nrp
 D9T192 - Micromonospora aurantiaca - Actinobacteria - ? - T2pks-nrps-transatpks - Nrp-Mal-Cys-Mal-Thr
 C7PXR3 - Catenulispora acidiphila - Actinobacteria - ? - Nrps-transatpks-t1pks-t2pks - Nrp-Mal-Thr-Cys-Mal
 Q8GGP2 - Streptomyces atroolivaceus - Actinobacteria - ? - Nrps-transatpks - Ser-Nrp-Thr-Pk-Ser-Mal-Cys-Ala-Nrp
 A9ECY5 - Kordia algicida - Bacteroidetes - ? - Transatpks-t2pks- ?
 F8TUA6 - Lysobacter sp. - Gammaproteobacteria - ? - Lantipeptide-nrps-transatpks - Leu-Leu-Phe-Leu-Leu-Nrp-Ile-Thr-Gly-Asn-Ser
 1c7g
 B6IZA3 Coxiella burnetii - Gammaproteobacteria - ? - ? - ?
 2jis
 Q6E7J8 - Lyngbya majuscula - Cyanobacteria - Mal, Nrp - T1pks-t2pks-nrps - Pk-Pk-Pk-Mal-Mal-Mal-Nrp-Mal-Ala-Mal
 1bs0
 K0EZM3 - Nocardia brasiliensis - Actinobacteria - ? - Terpene - ?
 A1ZVW4 - Microscilla marina - Bacteroidetes - Nrp - ? - ?
 B6VRQ8 - Streptomyces griseoviridis - Actinobacteria - Mal - T1pks - Nrp-Pk-Mal
 B3EYK4 - Anabaena circinalis - Cyanobacteria - ? - ? - ?
 3tqx
 D6B3S9 - Streptomyces albus - Actinobacteria - ? - T1pks - Gly-Mal-Mal
 A3ZWL3 - Blastopirellula marina - Planctomycetes - ? - ? - ?















Figure 2 Topology of the unrooted consensus tree calculated from the multiple alignment of the non-redundant set of type I
domains. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next
to the branches whenever the value was greater than 50. Sequences are labeled by their UniProt code and the following information, in order:
specie name, phylum, specificity, cluster type and product (definitions refers to those reported in Table 2). Question mark denotes unknown
information. Red circles indicate reference structures identified by their PDB id codes: [PDB:2E7U] is glutamate-1-semialdehyde 2,1-aminomutase
from Thermus termophilus; 1DGE, dialkylglycine decarboxylase from Burkholderia cepacia; [PDB:1VEF], acetylornithine aminotransferase from
Thermus termophilus; [PDB:3A2B], serine palmitoyltransferase from Sphyngobacterium multivorum; [PDB:1BS0], 8-amino-7-oxononanoate synthase
from Escherichia coli; [PDB:3TQX], 2-amino-3-ketobutyrate coenzyme A ligase from Coxiella burnetii; [PDB:1C7G], tyrosine phenol-lyase from Erwinia
herbicola; [PDB:2JIS], cysteine sulfinic acid decarboxylase from Homo sapiens. Subtrees defining the four families are drawn with different colours.
The tree is unrooted.
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PLP type I domain from polyketide synthase from
Burkholderia thailandensis [UniProt:Q2T5Z2] and the
structure of glutamate-1-semialdehyde 2,1-aminomu-
tase from Thermus thermophilus (GSA) [PDB:2E7U],
sharing 40% sequence identity. The Aminotran_1_2
group was represented by the type I domain from
the AMP-binding enzyme from Synechococcus sp.
[UniProt:B1XHP8] modeled onto the template serine
palmitoyltransferase from Sphingobacterium metilo-
vorum [PDB:3A2B]. Sequence identity shared by
the two sequences was 42%. Beta_elim_lyase family
was modeled using the domain from the keto-hydroxyglutarate-aldolase/polyketide synthase from Lyso-
bacter sp. [UniProt:F8TUA6]. The template was the tyro-
sine phenol-lyase from Erwinia herbicola [PDB:1C7G], that
shares about 24% sequence identity to the target sequence.
Pyridoxal_deC family was modeled using the type I target
sequence from the nonribosomal peptide synthetase
module from Coxiella burnetii [UniProt:B6IZA3] and the
template structure of human cysteine sulfinic acid de-
carboxylase [PDB:2JIS]. In this case, sequence identity
reached 33%. Alignments used for homology modelling
in each subfamily are reported in Figure 3.
Scrutiny of the pairwise and multiple sequence align-
ments within the four families along with the analysis of
Table 2 List of non redundant NRPS/PKS proteins containing type I PLP-dependent domains of the four families
UniProt code Specie B6dba) Domain layoutb) Specificityc) Cluster typed) Producte)
Family: Aminotran_3
1. A1YBQ7 Sorangium cellulosum ? CP–KS–CP–CP–ABHy6–PLP1 ? T1pks Mmal-Mmal-Mal-Mmal-Mal-Mmal-
Mal-Mal-Pk
2. C3AKA5 Bacillus mycoides GSA KS–CP–PLP1 ? Nrps-transatpks Asn-Mal-Gly-Nrp-Nrp-Nrp-Thr-Gly
3. C5B3B9 Methylobacterium
extorquens
TPA CP–ABHy–PLP1–FMO ? ? ?
4. C6XWU5 Pedobacter heparinus GSA A–CP–KS–AT–CP–PLP1 Nrp Nrps-t1pks Nrp-Mal-Gly-Pk
5. C8RZN9 Rhodobacter sp. SW2 DAT KS–AT–ADHN–ADHznN–KR–CP–PLP1 Mal Terpene-t1pks Mal
6. D3VEV4 Xenorhabdus nematophila GSA CP–PLP1–C–A–CP Nrp T1pks-nrps Nrp-Mal-Nrp-Asn
7. D6KDX7 Streptomyces sp. e14 GSA CP–PLP1–C ? Nrps Nrp-Mal-Nrp-Orn-Asp-Nrp-Nrp-Thr
8. E1TD76 Burkholderia sp. DAT CP–PLP1–SDH ? ? ?
9. F4CRB0 Pseudonocardia
dioxanivorans
DOT A–CP–PLP1 ? ? ?
10. F5RC11 Methyloversatilis
universalis
OAT CP–ABHy6–PLP1–FMO ? ? ?
11. F7QBN5 Salinisphaera shabanensis
E1L3A
GSA C–A–CP–KS–AT–CP–PLP1–C–HxxPF–A–CP Gly,- Nrps-t1pks Gly-Mal-Nrp
12. F9UAS6 Thiocapsa marina 5811 GSA KS–AT–CP–PLP1 Mal Nrps-t1pks Nrp-Nrp-Mal-Gly
13. G0PR31 Streptomyces griseus GSA PLP1–Luc–C–HxxPF–CP–C ? T1pks-nrps Mal-Thr
14. G2E5C9 Thiorhodococcus drewsii
AZ1
GSA A–CP–KS–AT–CP–PLP1–C–CP–C–HxxPF–C–HxxPF–A–CP–C–HxxPF Mal, Thr Nrps-t1pks Nrp-Tyr-Pk-Mal-Thr-Asp
15. Q2T5Z2 Burkholderia thailandensis GSA KS–AT–CP–PLP1–C–HxxPF–A–CP–C Asp Nrps-t1pks-hserlactone Mal-Asp-Gln-Cys-Pk-Val-Mal-Ala
Family: Aminotran_1_2
1. A1ZVW4 Microscilla marina AOS A–CP–PLP2 Nrp ? ?
2. A3ZWL3 Blastopirellula marina AOS A–CP–PLP2 ? ? ?
3. B3EYK4 Anabaena circinalis AOS CP–PLP2 ? ? ?
4. B6VRQ8 Streptomyces griseoviridis AOS A–CP–KS–AT–PLP2 Mal T1pks Nrp-Pk-Mal
5. B6VRS3 Streptomyces griseoviridis AOS CP–CP–PLP2 ? T1-pks Nrp-Pk-Mal
6. D6B3S9 Streptomyces albus J1074 AOS KR–CP–PLP2 ? T1pks Gly-Mal-Mal



































4. A9ECY5 Kordia algicida TPL CP–DUF2156–PLP3–KS–KR–CP–KS ? transatpks-t2pks Pk-Mal
5. F2LI38 Burkholderia gladioli TPL CP–KS–KR–CP–PLP3–KS–CP–KS ? T2pks-transatpks-nrps Mal-Gly-Nrp





1. Q6E7J8 Lyngbya majuscula DDC KS–AT–ADH–KR–CP–C–HxxPF–A–PLP4–A–CP Mal, Nrp T1pks-t2pks-nrps Pk-Pk-Pk-Mal-Mal-Mal-Nrp-Mal-Ala-
Mal
2. B6IZA3 Coxiella burnetii GDC A–CP–C–PLP4 Gly Nrp Gly
a)Family assignment with B6db. Abbreviations mean: GSA = Glutamate-1-semialdehyde 2,1-aminomutase; TPA = Taurine--pyruvate aminotransferase; DAT = Diamine aminotransferase; DOT = Diaminobutyrate-2-
oxoglutarate transaminase; OAT = Ornithine--oxo-acid aminotransferase; AOS = 8-amino-7-oxononanoate synthase, TPL = Tyrosine phenol-lyase; DDC = Diaminobutyrate decarboxylase; GDC = Glutamate
decarboxylase. Question mark means “not assigned”.
b)Domain codes with Pfam id code in parentheses: A = AMP–binding enzyme (PF00501); CP = Phosphopantetheine attachment site (PF00550); KS = beta–ketoacyl synthase (PF00109); AT = Acyltransferase domain
(PF00698); MT = Methyltransferase domain (PF13489); C = Condensation domain (PF00668); HxxPF = HxxPF–repeated domain (PF13745); Luc = Luciferase (PF00296); ABHyX = Alpha/beta hydrolase fold where X is the
subgroup number; FMO = Flavin–containing monooxygenase (PF00743); ADHN = Alcohol dehydrogenase GroES–like domain (PF08240); ADHZnN = Zinc–binding dehydrogenase (PF00107); KR = Ketoreductase domain
(PF08659); DUF4009 = Domain of unknown function (PF13193); SDH = Shikimate/quinate 5–dehydrogenase (PF01488); ECH = Enoyl–CoA hydratase/isomerase family (PF00378). Type-I domains are: PLP1 = Aminotran_3
(PF00202); PLP2 = Aminotran_1_2 (PF00155); PLP3 = Beta_elim_lyase (PF01212); PLP4 = Pyridoxal_deC (PF00282).
c)Predicted specificity of the AT or A domains of the chain containing the type-I domain. Nrp means generic amino acid (no consensus among the predictive methods). Question mark denotes no prediction. Mal and
Pk represent malonyl and a generic polyketide, respectively.
d)Gene cluster type as predicted by antiSMASH. Pks and Nrps stand for Polyketide synthase and Non-ribosomal polypeptide synthetase, respectively. T1pks, T2pks, transatpks refer to Type-I, Type-II and trans-AT pks,
respectively. Question mark denotes no prediction.


















Figure 3 Sequence alignment between a representative sequence of each family of type I domains and the most similar structural
template. Sequences are labeled by their databank code. Aminotran_3 (a): [UniProt: Q2T5Z2] indicates polyketide synthase from Burkholderia
thailandensis; [PDB:2E7U] is the glutamate-1-semialdehyde 2,1-aminomutase from Thermus thermophilus HB8. Aminotran_1_2 (b): [UniProt:B1XHP8]
indicates AMP-binding enzyme from Synechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6); [PDB:3A2B] denotes serine palmitoyltransferase
from Sphingobacterium multivorum. Beta_elim_lyase (c): [UniProt:F8TUA6] corresponds to keto-hydroxyglutarate-aldolase/polyketide synthase from
Lysobacter sp.; [PDB:1C7G] labels the tyrosine phenol-lyase from Erwinia herbicola. Pyridoxal_deC (d): [UniProt:B6IZA3] is the non-ribosomal peptide
synthetase module from Coxiella burnetii; [PDB:2JIS] stands for the cysteine sulfinic acid decarboxylase from Homo sapiens. Secondary structures
are charted below the template sequence. Helices (alpha and 310 helices are designated by α or η respectively) are displayed as squiggles and
beta strands (β) are rendered as arrows. Beta turns are denoted as “TT” and strict α turns as “TTT”. Dots indicate gaps. Identically conserved
residues are displayed on a red background; red letters indicate conservative substitutions. Triangles mark residues known to be functionally
important in the template enzyme. Black circles tag important residues from the other subunit. Stars label the Asp and the Lys residue involved in
interaction with pyridine nitrogen and in Schiff-base forming, respectively. The black square in the panel (c) indicates the Arg381 of the template
missing in the homologous PLP domain.
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of residues functionally important in the template en-
zymes. In particular, the aspartate residue interacting
with the pyridine nitrogen atom of pyridoxal 5′ -
phosphate is identically conserved in all the four fam-
ilies. The lysine forming the Schiff base with the cofactor
aldehydic group is also conserved, as expected, although
it is replaced by the residue Thr in the domains
from Methylobacterium extorquens [UniProt:C3B5B9]
and [UniProt:H1KFY7], Methyloversatilis universalis
[UniProt:F5RC11], and by Val in the protein from Soran-
gium cellulosum [UniProt:A1YBQ7] (Additional file 1: Fig-
ure S2). The Aminotran_3 group is characterized by a
short insertion of approximately 12 residues (Figure 3a) oc-
curring at the template positions 288–289 (the numberinga
c
Figure 4 Structural superposition of the model-template pairs. Structu
(a), Aminotran_1_2 (b), Beta_elim_lyase (c) and Pyridoxal_deC (d) reported
colored in grey. Green and cyan indicate the model subunits. Cofactor is re
deletion regions that are distinguished by magenta or yellow colors. The c
group (a) has no structural meaning: it has been modeled only with the pusystem refers to the template structure). This insertion is
portrayed as a loop on the surface of the model reported
in Figure 4a. Likewise, the template region 364–378 cor-
responding to a short surface helix that contributes to
the formation of the active site edge (Figure 4a), is absent
in the model domain. Among the residues at the active
site (Figure 5a), Tyr143 (template numbering system in
Figure 3a) makes stacking interaction with the PLP
ring and is conserved in many sequences of the same
family. Val239, the other residue sandwiching the cofac-
tor, is not conserved; in fact, it is replaced by the hydro-
phobic side chainS Ile, Leu, Ala, Met and, in three cases,
by Thr (Additional file 1: Figure S2a). Several residues
involved in the binding of the cofactor phosphate group
are also conserved, for example Asn114, Glu118 andb
d
ral superposition of the model-template pairs for families Aminotran_3
in Figure 3. Ribbon representation is used. Structural templates are
presented by transparent yellow spheres. Arrows point to insertion or
onformation of inserted magenta loop in the model of Aminotran_3
rpose to indicate its approximate location on the protein surface.
Figure 5 Comparisons of the models of the active site of the domains representative of each type I subfamily. Grey drawing indicates
the reference structural template, while orange and cyan depict the two subunits of the models. Cofactor is drawn as transparent yellow spheres
encapsulating stick models. Relevant side chains are rendered as sticks. Numbering refers to Figure 3. (a) Type I domain from polyketide synthase
from Burkholderia thailandensis [UniProt:Q2T5Z2], and glutamate-1-semialdehyde 2,1-aminomutase from Thermus thermophilus HB8 (internal
aldimine) [PDB:2E7U]. (b) AMP-binding enzyme [UniProt:B1XHP8] from Synechococcus sp. (strain ATCC 27264/PCC 7002/PR-6), and serine
palmitoyltransferase from Sphingobacterium multivorum (external aldimine with serine) [PDB-3A2B]. (c) keto-hydroxyglutarate-aldolase/polyketide
synthase from Lysobacter sp. [UniProt:F8TUA6] and tyrosine phenol-lyase from Erwinia herbicola (internal aldimine) [PDB:1C7G]. (d) Nonribosomal
peptide synthetase module from Coxiella burnetii [UniProt: B6IZA3] and cysteine sulfinic acid decarboxylase from Homo sapiens (internal
aldimine) [PDB:2JIS].
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terized aminotransferase domain of the enzyme MycA
from Bacillus subtilis involved in the synthesis of the cyc-
lic lipopeptide mycosubtilin [15], belongs to this family
[UniProt :Q9R9J1]. The amine source for the MycA en-
zyme was proved to be the amino acid Gln. Most of the
residues occurring at the active site of the model of the
representative domain (Figure 5a) are identically con-
served in the homologous sequences (Additional file 1:
Figure S2a) suggesting that the substrate Gln may be the
amine donor utilized by many of the other domains of
the same Aminotran_3 family. Indeed, the docking of
Gln into the active of the model (Additional file 1: Figure
S3a) shows favorable interactions with the evolutionarily
conserved residues observed also in the GSA template.
The α-amino group is stabilized by an ion-pair inter-
action with Glu395. Thr297 of the other subunit is
involved in a hydrogen bond to the carboxylate group
of the substrate. Arg25 binds the carboxylic group of
the substrate and is identically conserved in the polyke-
tide synthase from Burkholderia thailandensis [UniProt:
Q2T5Z2]. This Arg corresponds to a residue observedto be invariant in the GSA subfamily [25]; it presumably
required for binding the substrate carboxylate group
through a salt bridge. Finally, the δ-amino group of Gln
forms a hydrogen bond with the conserved Ser22 resi-
due. However, it should be noted that Arg25 and Ser22
residues occur in a non-conserved region of the type I
domains where sequence alignment is intrinsically less
accurate (Additional file 1: Figure S2a) and therefore the
indications from the docking simulations are less
reliable.
In the Aminotran_1_2 group, residues sandwiching
the PLP cofactor, namely His137 and Ala211 (numbering
refers to the template structure, Figure 3b), are invariant
in all the homologous sequences considered (Figure 5b
and Additional file 1: Figure S2b). Thr111 and Ser272
from the other subunit interact with the cofactor phos-
phate group and are conserved. His212 in Figure 5b is
involved in the interaction with the O3 atom of PLP and
is identically conserved in the homologous sequences.
Regarding the binding of the substrate, it can be ob-
served that His137 is involved in the binding of the sub-
strate carboxylate [26]. The same role is predicted in the
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ology model (Additional file 1: Figure S3b). Likewise,
Arg366 should also be mentioned among the residues
involved in substrate binding in the serine palmitoyl-
transferase template. This residue is identically con-
served and it is essential for the catalysis because it
forms the key PLP:L-serine quinonoid intermediate that
condenses with palmitoyl-CoA [27]. Finally, according to
the docked model of the PLP:L-serine quinonoid
intermediate, the β-hydroxyl moiety of the substrate
participates to a hydrogen bond with Ser242, residue con-
served in all the selected members of the Aminotran_1_2
family (Additional file 1: Figure S2b).
Active site model of the type I domain representative of
the Beta_elim_lyase family shows that some residues rele-
vant for catalysis in the representative member of the group
tyrosine phenol-lyase [28] are conserved. For example,
Phe105 and Thr198, the residues sandwiching the PLP co-
factor, are conserved (Figure 5c and Additional file 1: Figure
S2c) although the latter residue is replaced by Ser in one
case. The residues Arg386, Arg199 and Asn167, deemed to
be involved in interaction with the carboxylic group of the
reaction intermediate in tyrosine phenol-lyase, are con-
served (Additional file 1: Figure S3c). On the contrary, resi-
dues that in the postulated mechanism of β-elimination
reaction carry out the protonation of the substrate Cγ, are
not present in the Beta_elim_lyase of type I embedded in
multidomain context. In particular, Tyr53 of tyrosine
phenol-lyase is replaced by an Arg residue in the model do-
main, while Arg381 that assists Tyr53 during the proton-
ation is deleted in all the sequences reported in Additional
file 1: Figure S2c, including the PLP domain involved in the
biosynthesis of leinamycin [UniProt:Q8GGP2].
The Pyridoxal_deC group is the least populated; as-
sessment of evolutionary conservation of residues pos-
sibly involved in catalysis is more difficult. His111 and
Ala193 that, as in the Aminotran_1_2 family sandwich
the PLP ring, are conserved. His222 and Ser71, ligands
of the cofactor phosphate group, are also conserved. Ac-
cording to the docked model (Additional file 1: Figure
S3d), the α-carboxylate group of the substrate is
stabilized by an ion-pair interaction with Arg384. This
residue is equivalent to Arg567 in glutamic acid decarb-
oxylase, enzyme of the same family, that is responsible
for the formation of a salt bridge to its substrate γ-
aminobutyric acid [29]. Similarly Tyr253, the catalytic
residue of the Group II decarboxylases that performs the
protonation of the Cα atom of the quinonoid intermediate
[29], is conserved.
Prediction of protein-protein interaction sites on the
homology models of the type I domains
Prediction of the presence of potential protein-protein
binding sites was carried out for the models and therelative template structures in their dimeric forms. The
results suggest that some type I domains covalently in-
corporated in multidomain contexts possess potential
protein binding sites missing in the equivalent regions of
their respective structural templates. These regions are
in proximity of the active sites and contain residues
largely conserved in the corresponding homologs. In
particular, the Aminotran_3 domain displays a small
potential region encompassing the high interaction-
probability residues Phe25, Ile29, Lys30, Met32, Asp380
and Gly396 (positions are relative to the template num-
bering system in Figure 3a). The first four residues are
located in the poorly conserved N-terminal region
(Additional file 1: Figure S2a). Along with the other po-
tentially interacting sites, they form a region around the
active site mouth. The Aminotran_1_2 domain shows a
surface region predicted as potential protein-protein
interaction site that includes Asp333 and the sequence
Ala353-Lys362 (the positions refer to the template num-
bering system in Figure 3b). This region is located on
the rim of the active site. However, the potentially inter-
acting surface of the model is, in this case, similar to that
observed in the structural template (Additional file 1:
Figure S4b). The putative interaction between the CP
and the type I domains of polyketide synthase from Bur-
kholderia thailandensis [UniProt:Q2T5Z2] have been
predicted by protein-protein docking simulation using
the ClusPro server [30]. The homology model of the CP
domain encompassed by the positions 932–998 of
[UniProt: Q2T5Z2] has been calculated using the templates
denoted by [PDB:2EHS], [PDB:1X3O], [PDB:2QNW] and
[PDB:2JU2]. Although the results deriving from the docking
experiments carried out with homology models should be
considered with the great caution, it is interesting to note
that the ten best complexes calculated by the ClusPro
analysis suggest that the CP domain may interact with the
surface regions of the PLP domain predicted as potential
protein-protein interaction sites (Additional file 1: Figure
S5). The Beta_elim_lyase model possesses a wide surface
predicted as a potential interaction site, significantly
larger than that predicted in the corresponding struc-
tural template (Additional file 1: Figure S4c). The
interacting surface clusters into two patches located in
the proximity of the active site. The first cluster is
centered on the residues Arg343, His420, Gly423,
Gly424, Pro431 and Tyr432. The second cluster incor-
porates the residues Leu104, Phe105, Pro106, Ile109
and Tyr110. The Pyridoxal_deC family, represented by
the model of type I domain in the nonribosomal
peptide synthetase module from Coxiella burnetii
[UniProt:B6IZA3], displays a surface interaction pro-
pensity similar to the reference template structure of
human cysteine sulfinic acid decarboxylase [PDB:2JIS]
(Figure 3d). However, according to multiple sequence
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and the other known members of the Group II decar-
boxylases family, the characteristic third N-terminal
domain (N-domain) formed by three α-helices that fold
upon dimerization [31], is lost in Pyridoxal_deC family
upon incorporation in a multidomain context. It is
therefore tempting to speculate that this structural de-
letion, which would result in an alternate entry into
the active site, has evolved to accommodate the adja-
cent domains of the NRPS framework, e.g., a phospho-
pantetheine binding domain, and that α-
decarboxylation could occur on the amino acid sub-
strate tethered to the phosphopantetheine arm.
Discussion
In this work we focused specifically on the type I PLP do-
mains involved in putative bacterial NRPS and/or PKS as-
semblies as tailoring domains operating in cis. We collected
a set of predicted type I PLP sequences incorporated in
multidomain environments from eubacterial sources using
the HMM search using the PLP_domain profile. Only those
sequences containing a phosphopantetheine binding do-
main (CP) were considered. In most cases, the type I
domains are placed downstream from a CP domain
(Additional file 1: Table S1). As a test, the selection of se-
quences was carried out using as a criterion the association
of the type I domains with adenylation, condensation or
acyltransferase domains. In all cases, only subsets of the
group of sequences retrieved with the original requirement
were recovered, showing the correctness of the adopted
procedure. The only exception to this “rule” was the
β-ketoacyl synthase from Streptomyces violaceusniger
[UniProt:G2P368]. This 1136 residue long sequence is atyp-
ical since it does not possess a recognizable phospho-
pantetheine binding domain and displays a segment,
containing about 400 residues, in the central sequence
region apparently lacking any relation to known Pfam
domains. In a few cases [UniProt:G8X2R2] or [UniProt:
Q82RP2], Pfam annotation does not report the presence of
a CP domain. However, we were able to detect those do-
mains using the “Pfam_scan.pl” annotation script. In some
cases, use of a locally installed program provides an effect-
ive way of finely tuning the parameters.
The assemblies containing the type I domains we col-
lected, were found only in the following eubacterial phyla:
Acidobacteria, Actinobacteria, Bacteroidetes, Chloroflexi,
Cyanobacteria, Firmicutes, Planctomycetes, Proteobacteria,
and Verrucomicrobia. However, it should be considered
that the observed distribution may be significantly biased
by uneven species sampling.
Sequence alignments and phylogenetic analyses indi-
cated that four groups can be distinguished within the
collected set of the type I domains. The four groups
share the identical conservation (with the few exceptionsreported in Results section) of the key residues Asp and
Lys which are involved in interaction with the cofactor
pyridine nitrogen and in the formation of a Schiff base
with the aldehyde group of PLP, respectively.
We further studied the structural features characteriz-
ing these type I protein subfamilies by multiple sequence
alignment, homology modeling and search of the poten-
tial binding sites possibly involved in the interaction
with protein partners.
The most numerous group is the Aminotran_3
family which is structurally related to the glutamate 1-
semialdehyde-2,1-aminomutase [32]. The proteins be-
longing to this group are predicted to occur mainly in
mixed NRPS/PKS machineries. The aminotransferase
domain embedded in the multidomain PKS/NRPS
enzyme MycA from Bacillus subtilis involved in the
synthesis of the cyclic lipopeptide mycosubtilin [15], is
the example of the functionally characterized member
of the group. The role of the aminotransferase domain
is the insertion of the amino group into the polyketide
biosynthetic intermediate; the amine source for the
MycA enzyme was demonstrated to be glutamine [15].
A similar function was proposed also for the aminotransfer-
ase domains encoded by the genes mxcL and zea12
[13,14,33] from myxochelin and zeamine biosynthetic clus-
ters respectively, which belong to the same subfamily.
The multiple sequence alignment between a non-
redundant set of sequences and the reference modeling
template evidenced the structural features characteristic
of these domains. As shown in Figure 3a, there is an in-
sertion of about 12–14 residues at position 288–289
(numbering system of the structural template) that cor-
responds to the region 283–284 in Additional file 1:
Figure S2a. The insertion is located on the surface of the
domain (Figure 4a) and may be involved in modulating
the interaction with the adjacent domains and/or in sub-
strate recognition. Indeed, docking simulations suggests
that a loop is involved in interaction with the CP domain
(Additional file 1: Figure S5). In the surface area between
the sequence positions 364–378 of the alignment in
Figure 3a (corresponding to the region 364–378 in
Additional file 1: Figure S2a), a deletion region is
present. Further, the prediction of potential sites of
protein-protein interaction assigns a significant potential
to a region in the active site proximity, not visible in the
equivalent position of the structural template (Additional
file 1: Figure S4a). These observations, in particular the
presence of a wide region of potential protein-protein
interaction (Additional file 1: Figure S4b), suggest that
this structural feature could be required for productive
interaction with the adjacent domains in a multido-
main context.
The Aminotran_1_2 group is structurally related to
the Coenzyme A (CoA) family of the PLP-dependent
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mainly in PKS pathways. Within the CoA subfamily,
serine palmitoyltransferase is the most closely related
enzyme. Sequence alignments and homology modeling
indicate the conservation of the residues involved in
substrate-CoA interaction and the absence of long inser-
tion/deletions with respect to the structural template
(Figure 3b). Exception is the sequence of the type I do-
main from the Anabaena circinalis protein [UniProt:
B3EYK4] that shows two insertions, one of which 10-
residue long (Additional file 1: Figure S2b). The only ex-
perimentally characterized member of this family is the
PigH protein [UniProt: Q5W247] from Serratia marces-
cens [16], involved in the biosynthesis of the three-
pyrrolic red pigment prodigiosin. PigH contains two CP
domains followed by a type I PLP domain, SerT (as re-
ported in Additional file 1: Table S1), predicted to
catalyze the decarboxylation of L-serine and the forma-
tion of C2 fragment used in the formation of the pyrrole
B ring of prodigiosin. Analysis of surface of the hom-
ology model of the representative type I domain of this
family suggests the presence of an increased potential
for protein interaction in the proximity of the active site
mouth (Additional file 1: Figure S4b). However, the in-
crease of the interaction potential with respect to the
stand-alone counterpart is less evident than in the case
of the Aminotran-3 family.
Extensive remodeling of the protein surface can be
conjectured also for the Beta_elim_lyase family. In fact,
as in Aminotran_3 group a wide region of potential
protein-protein interaction (Additional file 1: Figure
S4b) is observed. The sequence divergence from the
model is evident at the N-terminal part of the domain.
This family is indeed characterized by domains occur-
ring mainly at the C-terminal edge of the multidomain
module. Despite the conservation of many active site key
residues observed in the tyrosine phenol-lyase enzyme,
some side chains involved in the catalytic mechanisms
are missing. In particular, as mentioned in the Results
section, Tyr53 of tyrosine phenol-lyase is replaced by an
Arg residue while Arg381 is missing. Although the rele-
vance of such variations on the functionality of these
domains cannot be presently assessed, it is worth men-
tioning that studies on classical β-eliminating lyases
showed how the mutation of the residues corresponding
to Arg381 and Tyr53 affected the activity of two proteins
belonging to this family. The substitution of Arg381 with
Ile and Val in tyrosine phenol-lyase caused a significant
impairment in the activity towards Tyr, but not in case
of other substrates; moreover the same substitutions
were present in the wild type and fully active tryptophan
indole-lyase enzymes [35]. Similarly, the replacement of
Tyr71 (corresponding to Tyr53) had different effects on
the activity of the protein towards different substrates[35]. These findings indicate that Tyr53 and Arg381 are
not absolutely indispensable for the catalytic activity of
all the PLP enzymes of this family. Regarding the predic-
tion of protein interaction sites on the type I domains,
the results suggest the presence of a wide area possibly
involved in the interaction with other protein partners
as observed in other aforementioned families.
The pyridoxal_deC family, the least numerous, is re-
lated to the decarboxylase family II [19] to which the en-
zyme glutamate decarboxylase belongs. However, the
most similar reference structure found was cysteine
sulfinic acid decarboxylase, an enzyme involved in hypo-
taurine biosynthesis [36] which functions as an autoanti-
gen in human endocrine autoimmune diseases [37].
Conservation of the residues essential for catalysis in
glutamate decarboxylase, which is better characterized
than cysteine sulfinic acid decarboxylase, suggests the
possible preservation of the decarboxylase activity in this
domain. The databank search showed that the patho-
genic proteobacterium Coxiella burnetii, whose genome
has been completely sequenced, possesses one of the
two Pyridoxal_deC domains found during our databank
searches. The other, showing high similarity with glu-
tamate decarboxylase domains, was found in the cyano-
bacterium Lyngbya majuscula, in particular in the
biosynthetic cluster of jamaicamide. Interestingly, it is
embedded within the adenylation domain of the PKS/
NRPS multidomain subunit JamL, but the precise func-
tion of the PLP-dependent domain in the biosynthesis of
this metabolite has not been so far clarified [38].
The results of our work show that the domains be-
longing to the type I PLP dependent enzymes linked to a
component of the multidomain frameworks related to
NRPS and/or PKS-like assemblies are relatively rare but
widespread among several bacterial phyla. These do-
mains display conservation (except in a few cases in
the Aminotran_3 family) of residues involved in
cofactor binding and catalysis. However the prediction
of protein-protein interaction sites suggests that the N-
and C-terminal ends of the domain polypeptide chain
display stronger sequence divergence with respect to
the reference stand-alone structures (Additional file 1:
Figure S2a). These regions are necessarily involved in
connecting the linkers bridging the other domains in the
multidomain subunits (Table 1). On the other hand, it
must stressed that predictions of interacting sites are still
very inaccurate and in this case they can be significantly
biased by modeling inaccuracies especially related to the
prediction of side chain solvent accessibility. Neverthe-
less, the differences between the prediction in the
surface regions possibly involved in protein-protein
interaction of the model and the templates are, at least
in the case of Aminotran_3 and Aminotran_1_2 groups,
very strong. These two families display the highest
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Therefore, the strong differences observed can represent
significant signals, while differences observed in the
models of other families are less reliable. This hypothesis
is supported by the results of the docking experiment
carried out using the homology model of the PLP type I
and CP domains of the Aminotran_3 family. Indeed, al-
though the results of docking experiments carried out
with homology models should be taken with the great
caution, the ten best complexes indicate that the CP do-
main may interact with the surface regions of the PLP
domain predicted as potential protein-protein inter-
action sites (Additional file 1: Figure S5).
In this context the quaternary architecture of multido-
main assemblies incorporating a PLP-dependent type I
domain should also be considered. Indeed, the PLP type
I domains are dimers or tetramers because the proper
formation of their catalytically competent active site re-
quires the participation of residues from the adjacent
subunits [39]. This structural constraint fits well with
the dimeric architecture of PKS systems. On the other
hand, studies with individual NRPS domains showed
that they were monomers [40]; however a dimeric struc-
ture was demonstrated in the multidomain synthetase
VibF and a continuum of monomeric and dimeric
oligomerization states in NRPS was proposed [41]. The
existence of a number of secondary metabolites of mixed
PKS/NRPS origin shows that the two biosynthetic ma-
chineries are compatible and studies on multienzyme
docking in hybrid megasynthetases indicated that NRPS
subunits in mixed systems self-associate to interact with
partner PKS homodimers [42].
Conclusions
This work offers a systematic view of the occurrence of
the type I PLP-dependent enzymes within NRPS and
PKS assembly lines and predicts their structural charac-
teristics using in silico methods. The results of this re-
search contribute to a deeper understanding of the
functional and structural diversity of the PLP-enzyme
family of fold type I and pave the way to further studies
aimed at their applications in combinatorial biosynthesis.
In fact, the success in the functioning of engineered bio-
synthetic clusters depends, to a great extent, on efficient
molecular recognition between the single components.
Methods
Data sources and computational tools
All sequence data processed during the work were taken
from the UniProt [43] release April, 2012 or Protein
Data Banks [44]. Most of the databank searches and ana-
lyses utilized the profile Hidden Markov Model (HMM)
methodology as implemented in the package HMMER
3.0 [45] or relied on the BLAST suite [46]. Multiplesequence alignments were calculated either with the
programs Clustal-W [47], MAFFT [48] or hmmalign
[45]; sequence editing and alignment display relied on
Jalview [49] or Seaview [50] editors.
Hidden Markov model of type I PLP-enzymes
A Hidden Markov Model (HMM) of the superfamily of
PLP-dependent enzymes of fold type I was calculated
with the HMMER v3.0 package [45]. A profile HMM is
normally calculated from a multiple alignment of a set
of appropriately selected sequences belonging to the
superfamily to be modeled. If the alignment is suffi-
ciently accurate, the model should be able to recognize
distantly related members of the same superfamily. Pro-
teins belonging to the fold type I superfamily are charac-
terized by sharing scant sequence identity, as low as 9%
[5]. This characteristic provides the opportunity to de-
sign a multiple sequence alignment able to encode the
structural fingerprint shared by all the members, even
very distant, of the superfamily. However, accurate cal-
culation of a multiple sequence alignment containing
distant sequences is intrinsically rather difficult and
strongly error-prone. This inherent difficulty has been
surmounted through use of the structure-based se-
quence alignments [5] implemented in Combinatorial
Extension [51] tool.
Databank searches
The identification and analysis of fold type I domains
within putative NRPS- or PKS-like frameworks relied on
a multistep procedure:
1) The program “hmmsearch” of the HMMER v3.0
package scanned the UniProt bacterial subset
(version April, 2012) using the PLP_domain query
profile. The search output was filtered for the
purpose of selecting multimodular sequences
containing genuine PLP-domains of fold type I. As
an initial and rough criterion, only hits embedded in
sequences longer than 1000 residue and overlapping
the query HMM profile for at least 110 residues
were taken into consideration. The sequence length
threshold assured that only enzymes within
multidomain contexts were collected since the
typical length of a stand-alone PLP enzyme is
around 400 residues. The sequence coverage
threshold was set taking into account that the total
residues involved in the SCRs of the PLP_domain
profile are 108. The limit should therefore assure
presence of the SCR residues in the significant hits.
Candidate sequences to be submitted to the
following steps were collected;
2) The set of sequences selected at the end of step 1
was further processed by the scripts “hmmscan” in
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at the Pfam site [52]. The scripts compare a
sequence against the Pfam database to locate known
domains. Only sequences containing at least one
phosphopantetheine (PP)-binding domain combined
with a type I PLP-domain were retained;
3) The sequences of the type I PLP domains surviving
the selection step 2, were extracted from the parent
sequences according to the position boundaries
assigned to them by the Pfam models. The excised
sequences were multiply aligned using the program
hmmalign [45] and a new HMM profile was
calculated. This profile is, by definition, specific for
recognizing type I domains embedded in
multidomain environments containing at least one
PP-binding motif. A new search has been carried
with this query profile;
4) Search output was filtered with the following
criteria: hits embedded in sequences longer than 500
residues and overlapping the query profile at least
110 residues, were retained; domain labeling was
again carried out and only sequences characterized
by the co-presence of PP-binding and type I
domains were considered. The minimum length was
set taking into consideration that the sum of the
lengths of a typical CP domain and a typical type I
enzymes is about 500 residues.
Domain annotation and assembly characterization
The organization and the identity of the domains con-
tained in the parent sequences from which the type I
domains were extracted, were determined through anno-
tation by means of the script Pfam_scan.pl. Gene cluster
identity, substrate specificity and product prediction
were carried out with the software pipeline anti-
SMASH v2 [22]. The type I domains isolated from the
parent sequences were also compared to the families
contained in the B6 database and assigned to one of
them [20].
Phylogenetic analyses
Phylogenetic analyses were carried out with the software
MEGA v5.1 [53]. The Minimum Evolution method [54] im-
plemented in the program was applied. Evolutionary dis-
tances were computed using the JTT matrix-based method
[55] and all positions containing gaps and missing data
were eliminated. A Bootstrap test with 1000 replicates was
used to assess the predicted topology of the resulting trees.
All the calculated trees were unrooted.
Protein structure analysis, modelling and docking
Protein structure superposition and inspection utilized
the Combinatorial Extension [51] and PyMOL graphics
program [56], respectively. Most of the data handlingwas carried out with Python or Perl scripts under the
Linux environment or utilized routines of the EMBOSS
suite [18]. Homology modeling made use of Modeller
v.9.9 [57] and PyMod [58]; models were validated with
standard programs such as ProsaII [59] and Procheck
[60]. Candidate templates for homology modeling were
assessed through the Phyre v2.0 server for protein fold
recognition [61]. Molecular docking relied on Molegro
Virtual Docker [62]. Candidate molecules were prepared
by adding explicit hydrogens, charges, and flexible tor-
sions. The side-chains of the active-site residues were
kept fixed during docking. A spherical energy grid with
a 15 Å radius, centered on the carboxylate moiety of the
aspartate residue interacting with the pyridine nitrogen
atom of pyridoxal 5′-phosphate, and a grid resolution of
0.30 Å was used. Other parameters were set at their de-
fault values: scoring function, MolDock score; search al-
gorithm: MolDock SE; number of runs: 10; maximum
iterations: 1500; maximum population size, 50; max-
imum number of poses returned, 5; cluster similar poses
with RMSD threshold: 1.00 Å. Only the highest scoring
pose, according to the MolDock scheme, was kept.
ESPript [63] produced figures of sequence alignments
while PyMOL [56] was the program for protein struc-
ture analysis and figure design. Prediction of the poten-
tial presence of protein-protein interaction sites was
carried out with the consensus method implemented in
meta-PPISP at the web site http://pipe.scs.fsu.edu/meta-
ppisp [64]. Protein-protein docking was carried out
using the ClusPro method available at the server http://
cluspro.bu.edu [30].Additional file
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